Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy
Clinical trial NCT06840834 · RECRUITING
Trial details
- NCT number
- NCT06840834
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2026-09-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.